A pharma company brand team preparing for the launch of a specialty treatment set out to better understand this patient population through a longitudinal patient journey analysis, using real world data to track patient behaviors and treatment progression over time. This launch brand was designed to replace an older product which had served as a third-line treatment, while its primary competitor enjoyed first- or second-line use. The brand teams’ key objectives were:
Clarivate assembled a team with expertise in analytics and social intelligence, well-grounded in the commercial and clinical context underpinning the category.
Leveraging Clarivate’s repository of anonymized claims data, the team identified patient cohorts and mapped them to relevant patient demographics. They then blended claims and social data sets to: